T-Spot.Tb8
Payments companies reported to CMS as associated with T-Spot.Tb8. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with T-Spot.Tb8, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with T-Spot.Tb8
These are the largest totals companies reported as associated with T-Spot.Tb8. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Paul Drain | Seattle, WA | Infectious Disease | $18,000.00 |
| Roy Chemaly | Houston, TX | Infectious Disease | $11,060.00 |
| Karen Kovalow-Stjohn | San Luis Obispo, CA | Rheumatology | $29.69 |
| Elena Spektor | Los Angeles, CA | $24.88 |
Prescribed T-Spot.Tb8?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.